Filgrastim

Details

Files

Generic Name:

Filgrastim

Project Status:

Complete

Therapeutic Area:

Neutropenia

Manufacturer:

Apotex Inc.

Call for patient/clinician input open:

August 12, 2015

Brand Name:

Grastofil

Project Line:

Reimbursement Review

Project Number:

SE0446-000

Call for patient/clinician input closed:

October 1, 2015

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Biosimilar:

Yes

Submission Type:

Initial

Indications:

Prevention or treatment of neutropenia in various indications

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

March 18, 2016

Last Updated : August 12, 2015